Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HAR3
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008233 | peptidase activity | 3 | 12 |
GO:0008234 | cysteine-type peptidase activity | 4 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
GO:0008242 | omega peptidase activity | 4 | 1 |
GO:0016920 | pyroglutamyl-peptidase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 38 | 40 | PF00082 | 0.437 |
CLV_PCSK_PC1ET2_1 | 38 | 40 | PF00082 | 0.437 |
CLV_PCSK_SKI1_1 | 82 | 86 | PF00082 | 0.419 |
DOC_CYCLIN_RxL_1 | 213 | 222 | PF00134 | 0.328 |
DOC_MAPK_HePTP_8 | 73 | 85 | PF00069 | 0.249 |
DOC_MAPK_MEF2A_6 | 5 | 12 | PF00069 | 0.399 |
DOC_MAPK_MEF2A_6 | 76 | 85 | PF00069 | 0.298 |
DOC_PP2B_LxvP_1 | 124 | 127 | PF13499 | 0.249 |
DOC_PP2B_PxIxI_1 | 254 | 260 | PF00149 | 0.293 |
DOC_PP4_FxxP_1 | 194 | 197 | PF00568 | 0.548 |
DOC_USP7_MATH_1 | 182 | 186 | PF00917 | 0.604 |
DOC_WW_Pin1_4 | 142 | 147 | PF00397 | 0.574 |
LIG_14-3-3_CanoR_1 | 47 | 53 | PF00244 | 0.522 |
LIG_APCC_ABBA_1 | 88 | 93 | PF00400 | 0.477 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.559 |
LIG_BRCT_BRCA1_1 | 144 | 148 | PF00533 | 0.355 |
LIG_FHA_1 | 121 | 127 | PF00498 | 0.269 |
LIG_FHA_1 | 129 | 135 | PF00498 | 0.403 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.464 |
LIG_FHA_1 | 223 | 229 | PF00498 | 0.499 |
LIG_FHA_1 | 92 | 98 | PF00498 | 0.477 |
LIG_FHA_2 | 241 | 247 | PF00498 | 0.565 |
LIG_LIR_Gen_1 | 107 | 115 | PF02991 | 0.477 |
LIG_LIR_Gen_1 | 145 | 155 | PF02991 | 0.538 |
LIG_LIR_Gen_1 | 45 | 55 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 107 | 112 | PF02991 | 0.486 |
LIG_LIR_Nem_3 | 13 | 18 | PF02991 | 0.338 |
LIG_LIR_Nem_3 | 145 | 151 | PF02991 | 0.537 |
LIG_LIR_Nem_3 | 45 | 51 | PF02991 | 0.471 |
LIG_Pex14_2 | 135 | 139 | PF04695 | 0.572 |
LIG_SH2_CRK | 215 | 219 | PF00017 | 0.377 |
LIG_SH2_STAP1 | 229 | 233 | PF00017 | 0.471 |
LIG_SH2_STAT5 | 208 | 211 | PF00017 | 0.370 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.451 |
LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.260 |
LIG_SH3_3 | 232 | 238 | PF00018 | 0.406 |
LIG_SUMO_SIM_par_1 | 121 | 129 | PF11976 | 0.249 |
LIG_SUMO_SIM_par_1 | 270 | 276 | PF11976 | 0.530 |
LIG_TYR_ITIM | 46 | 51 | PF00017 | 0.363 |
MOD_CK1_1 | 172 | 178 | PF00069 | 0.623 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.459 |
MOD_CK2_1 | 240 | 246 | PF00069 | 0.614 |
MOD_GlcNHglycan | 180 | 183 | PF01048 | 0.718 |
MOD_GlcNHglycan | 184 | 187 | PF01048 | 0.730 |
MOD_GlcNHglycan | 53 | 56 | PF01048 | 0.342 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.568 |
MOD_GSK3_1 | 178 | 185 | PF00069 | 0.495 |
MOD_GSK3_1 | 236 | 243 | PF00069 | 0.317 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.550 |
MOD_NEK2_1 | 120 | 125 | PF00069 | 0.289 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.558 |
MOD_NEK2_1 | 170 | 175 | PF00069 | 0.633 |
MOD_NEK2_1 | 51 | 56 | PF00069 | 0.482 |
MOD_NEK2_2 | 17 | 22 | PF00069 | 0.477 |
MOD_PKA_2 | 46 | 52 | PF00069 | 0.461 |
MOD_PKA_2 | 91 | 97 | PF00069 | 0.249 |
MOD_Plk_1 | 120 | 126 | PF00069 | 0.532 |
MOD_Plk_4 | 120 | 126 | PF00069 | 0.249 |
MOD_Plk_4 | 135 | 141 | PF00069 | 0.485 |
MOD_Plk_4 | 253 | 259 | PF00069 | 0.486 |
MOD_Plk_4 | 270 | 276 | PF00069 | 0.461 |
MOD_ProDKin_1 | 142 | 148 | PF00069 | 0.567 |
TRG_DiLeu_BaLyEn_6 | 150 | 155 | PF01217 | 0.480 |
TRG_ENDOCYTIC_2 | 105 | 108 | PF00928 | 0.373 |
TRG_ENDOCYTIC_2 | 15 | 18 | PF00928 | 0.431 |
TRG_ENDOCYTIC_2 | 215 | 218 | PF00928 | 0.372 |
TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.404 |
TRG_ENDOCYTIC_2 | 48 | 51 | PF00928 | 0.398 |
TRG_Pf-PMV_PEXEL_1 | 153 | 157 | PF00026 | 0.560 |
TRG_Pf-PMV_PEXEL_1 | 216 | 221 | PF00026 | 0.328 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8X3 | Leptomonas seymouri | 56% | 99% |
A0A0S4JYF2 | Bodo saltans | 30% | 95% |
A0A1X0P9S4 | Trypanosomatidae | 34% | 100% |
A0A3R7R5B2 | Trypanosoma rangeli | 31% | 100% |
A0A3S5H7W7 | Leishmania donovani | 73% | 100% |
A4I9X7 | Leishmania infantum | 72% | 100% |
C9ZMR0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 100% |
E9B4Y5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 72% | 100% |
Q4Q301 | Leishmania major | 71% | 100% |
V5BNH8 | Trypanosoma cruzi | 33% | 100% |